Pediatrix Medical Group (MD) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Pediatrix Medical Group · Health Care · ref. ETF XLV · 58 calls · price $26.61
What the company does: Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
📈 Pediatrix Medical Group (MD) stock price
$26.61+65.4% over range
Oct 14, 25low $16.09 · high $27.39Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 3 analysts
📊 JPI status : Pediatrix Medical Group is no longer in our current JPI rankings, but appeared in the past (2023) — its upside may be behind it. See the stocks picked in 2023 →
🎯 MD price target & analyst consensus — price $26.61
The price target · all analysts combined (3 targets)
Highest target · 3 firms of 3$28+5.2%
Median target · of 3 targets$28+5.2%
Lowest target · 3 firms of 3$28+5.2%
Current price$26.61
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Jefferies — 61% of its targets hit on this sector (137 calls tested). It aims for $28 (+5.2 %), call made on August 20, 2026, maturing on August 20, 2027 (55 d ago).
The 2 reliable analysts
$28+5.2 %
The 1 other firm
$28+5.2 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $28 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold3100%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 MD price target all
All 58 calls, one by one, with our verdict on each firm.
→ See all 58 targets, analyst by analyst💡 The best analysts on MD most reliable
Their real reliability on MD, firm by firm: who was right, who was wrong.
→ See their reliability on MDAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Pediatrix Medical Group? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on MD
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Macquarie ↗ | 100% | +58.6% | 2 |
| B of A Securities ↗ | 100% | +22.4% | 2 |
| Jefferies ↗ | 90% | +22.1% | 10 |
| Citigroup ↗ | 67% | +7.1% | 3 |
| Stifel ↗ | 57% | +6.3% | 7 |
| Piper Sandler ↗ | 50% | +9.9% | 2 |
| Deutsche Bank ↗ | 50% | -12.1% | 6 |
| UBS ↗ | 50% | -30.5% | 4 |
| Credit Suisse | 33% | -0.7% | 15 |
| Mizuho ↗ | 0% | -14.1% | 2 |
📊 What $1,000 invested in Pediatrix Medical Group would be worth › open the full page
In short — $1,000 invested in Pediatrix Medical Group 10 years ago would be worth $336 today, i.e. -10%/yr on average. Best year: 2025 (+63%), worst: 2022 (-45%). Price performance, excluding dividends.
If I'd invested $1,000 in Pediatrix Medical Group
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,838 | +84% |
| 3 years ago | $1,622 | +62% |
| 5 years ago | $982 | -2% |
Return by year (Pediatrix Medical Group)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +13% | $1,127 (+13%) |
| 2025 | +63% | $1,838 (+84%) |
| 2024 | +41% | $2,592 (+159%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Pediatrix Medical Group
Loading news…
📋 All analyst calls on MD
Filtered on — · ✕ show all
■ Hold neutral · not a buy · 🎯$28
Price at call : $26.22 — gap to target +7%
Today : $26.61 — gap to target +5%
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
■ Neutral neutral · not a buy · 🎯$28
Price at call : $27.08 — gap to target +3%
Today : $26.61 — gap to target +5%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Truist Securities ↗
Jul 14, 26
■ Hold neutral · not a buy · 🎯$28
Price at call : $25.88 — gap to target +8%
Today : $26.61 — gap to target +5%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
■ Neutral neutral · not a buy · 🎯$25
Price at call : $23.98 — gap to target +4%
Today : $26.61 — gap to target -6%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
Truist Securities ↗
Apr 13, 26
■ Hold neutral · not a buy · 🎯$23
Price at call : $22.61 — gap to target +2%
Today : $26.61 — gap to target -14%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
■ Neutral neutral · not a buy · 🎯$22
Price at call : $19.9 — gap to target +11%
Today : $26.61 — gap to target -17%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
Truist Securities ↗
Feb 20, 26
■ Hold neutral · not a buy · 🎯$21
Price at call : $19.74 — gap to target +6%
Today : $26.61 — gap to target -21%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Truist Securities ↗
Nov 10, 25
■ Hold neutral · not a buy · 🎯$24
Price at call : $22.61 — gap to target +6%
Today : $26.61 — gap to target -10%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
See the other 50 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$23
Price at call : $21.82 — gap to target +5%
Today : $26.61 — gap to target -14%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Leerink Partners ↗
Sep 5, 25
■ Market Perform neutral · not a buy · 🎯$17
Price at call : $17.07 — gap to target -0%
Today : $26.61 — gap to target -36%
🎯 on MD : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Sep 5, 26
matures : Sep 5, 26
■ Neutral neutral · not a buy · 🎯$16.5
Price at call : $16.04 — gap to target +3%
Today : $26.61 — gap to target -38%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Aug 14, 26
matures : Aug 14, 26
■ Neutral neutral · not a buy · 🎯$16
Price at call : $14.42 — gap to target +11%
Today : $26.61 — gap to target -40%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : May 12, 26
matures : May 12, 26
▲ Outperform · 🎯$20
Price at call : $14.44 — upside +39%
Today : $26.61 — upside -25%
Expected +39% · Actual +63% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 100% (2 calls matureds) · 📊 on Health : 40% · +4.7% (10 calls)
+62.8%
stock +63% · XLV +7%
matured May 8, 26
Truist Securities ↗
Apr 11, 25
■ Hold neutral · not a buy · 🎯$16
Price at call : $13.34 — gap to target +20%
Today : $26.61 — gap to target -40%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Apr 11, 26
matures : Apr 11, 26
■ Neutral neutral · not a buy · 🎯$18.5
Price at call : $15.68 — gap to target +18%
Today : $26.61 — gap to target -30%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Feb 21, 26
matures : Feb 21, 26
Truist Securities ↗
Feb 21, 25
■ Hold neutral · not a buy · 🎯$18
Price at call : $15.68 — gap to target +15%
Today : $26.61 — gap to target -32%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Feb 21, 26
matures : Feb 21, 26
Truist Securities ↗
Jan 6, 25
■ Hold neutral · not a buy · 🎯$15
Price at call : $12.8 — gap to target +17%
Today : $26.61 — gap to target -44%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jan 6, 26
matures : Jan 6, 26
▲ Outperform · 🎯$18
Price at call : $14.45 — upside +25%
Today : $26.61 — upside -32%
Expected +25% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 100% (2 calls matureds) · 📊 on Health : 40% · +4.7% (10 calls)
+54.5%
stock +54% · XLV +11%
matured Dec 16, 25
■ Neutral neutral · not a buy · 🎯$15
Price at call : $14.61 — gap to target +3%
Today : $26.61 — gap to target -44%
🎯 on MD : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Nov 19, 25
matures : Nov 19, 25
■ Neutral neutral · not a buy · 🎯$16.5
Price at call : $16.08 — gap to target +3%
Today : $26.61 — gap to target -38%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Nov 5, 25
matures : Nov 5, 25
▲ Buy · 🎯$18
Price at call : $15.36 — upside +17%
Today : $26.61 — upside -32%
Expected +17% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
+41.2%
stock +41% · XLV -1%
matured Nov 5, 25
Deutsche Bank ↗
Nov 4, 24
■ Hold neutral · not a buy · 🎯$15
Price at call : $15.36 — gap to target -2%
Today : $26.61 — gap to target -44%
🎯 on MD : no call matured yet · 📊 on Health : 33.9% · -7.0% (56 calls)
in progress (365j)
matures : Nov 4, 25
matures : Nov 4, 25
Truist Securities ↗
Nov 4, 24
■ Hold neutral · not a buy · 🎯$16
Price at call : $15.36 — gap to target +4%
Today : $26.61 — gap to target -40%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Nov 4, 25
matures : Nov 4, 25
■ Neutral neutral · not a buy · 🎯$15
Price at call : $15.14 — gap to target -1%
Today : $26.61 — gap to target -44%
🎯 on MD : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Nov 4, 25
matures : Nov 4, 25
Truist Securities ↗
Oct 7, 24
■ Hold neutral · not a buy · 🎯$13
Price at call : $11.95 — gap to target +9%
Today : $26.61 — gap to target -51%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Oct 7, 25
matures : Oct 7, 25
▲ Buy · 🎯$14
Price at call : $11.26 — upside +24%
Today : $26.61 — upside -47%
Expected +24% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
+44.0%
stock +44% · XLV -11%
matured Sep 26, 25
Truist Securities ↗
Aug 15, 24
■ Hold neutral · not a buy · 🎯$10
Price at call : $10.3 — gap to target -3%
Today : $26.61 — gap to target -62%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Aug 15, 25
matures : Aug 15, 25
■ Neutral neutral · not a buy · 🎯$10.5
Price at call : $10.13 — gap to target +4%
Today : $26.61 — gap to target -61%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Aug 9, 25
matures : Aug 9, 25
Truist Securities ↗
Jul 15, 24
■ Hold neutral · not a buy · 🎯$8
Price at call : $7.62 — gap to target +5%
Today : $26.61 — gap to target -70%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 15, 25
matures : Jul 15, 25
Deutsche Bank ↗
Jun 7, 24
■ Hold neutral · not a buy · 🎯$8
Price at call : $7.12 — gap to target +12%
Today : $26.61 — gap to target -70%
🎯 on MD : no call matured yet · 📊 on Health : 33.9% · -7.0% (56 calls)
in progress (365j)
matures : Jun 7, 25
matures : Jun 7, 25
Truist Securities ↗
May 15, 24
■ Hold neutral · not a buy · 🎯$10
Price at call : $7.79 — gap to target +28%
Today : $26.61 — gap to target -62%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : May 15, 25
matures : May 15, 25
■ Hold neutral · not a buy · 🎯$9
Price at call : $8.84 — gap to target +2%
Today : $26.61 — gap to target -66%
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Mar 6, 25
matures : Mar 6, 25
■ Neutral neutral · not a buy · 🎯$9
Price at call : $8.58 — gap to target +5%
Today : $26.61 — gap to target -66%
🎯 on MD : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Feb 20, 25
matures : Feb 20, 25
Truist Securities ↗
Feb 21, 24
■ Hold neutral · not a buy · 🎯$10
Price at call : $8.66 — gap to target +15%
Today : $26.61 — gap to target -62%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Feb 20, 25
matures : Feb 20, 25
■ Neutral neutral · not a buy · 🎯$9.5
Price at call : $8.38 — gap to target +13%
Today : $26.61 — gap to target -64%
🎯 on MD : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Nov 29, 24
matures : Nov 29, 24
Truist Securities ↗
Oct 11, 23
■ Hold neutral · not a buy · 🎯$15
Price at call : $11.78 — gap to target +27%
Today : $26.61 — gap to target -44%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Oct 10, 24
matures : Oct 10, 24
Truist Securities ↗
May 9, 23
■ Hold neutral · not a buy · 🎯$15
Price at call : $13.46 — gap to target +11%
Today : $26.61 — gap to target -44%
🎯 on MD : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : May 8, 24
matures : May 8, 24
Credit Suisse
Feb 22, 23
▲ Outperform · 🎯$23
Price at call : $15.94 — upside +44%
Today : $26.61 — upside -14%
Expected +44% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on MD : 0% (6 calls matureds) · 📊 unranked overall
-46.2%
stock -46% · XLV +13%
matured Feb 22, 24
Credit Suisse
Dec 5, 22
▲ Outperform · 🎯$27
Price at call : $15.67 — upside +72%
Today : $26.61 — upside +1%
Expected +72% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on MD : 0% (6 calls matureds) · 📊 unranked overall
-41.9%
stock -42% · XLV -5%
matured Dec 5, 23
■ Neutral neutral · not a buy · 🎯$17
Price at call : $15.73 — gap to target +8%
Today : $26.61 — gap to target -36%
🎯 on MD : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Nov 16, 23
matures : Nov 16, 23
SVB Leerink
Nov 4, 22
■ Market Perform neutral · not a buy · 🎯$16
Price at call : $15.61 — gap to target +2%
Today : $26.61 — gap to target -40%
🎯 on MD : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 4, 23
matures : Nov 4, 23
Credit Suisse
Aug 11, 22
▲ Outperform · 🎯$28
Price at call : $21.23 — upside +32%
Today : $26.61 — upside +5%
Expected +32% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on MD : 0% (6 calls matureds) · 📊 unranked overall
-31.4%
stock -31% · XLV +2%
matured Aug 11, 23
BMO Capital ↗
Aug 10, 22
■ Market Perform neutral · not a buy · 🎯$23
Price at call : $21.04 — gap to target +9%
Today : $26.61 — gap to target -14%
🎯 on MD : no call matured yet · 📊 on Health : 43.3% · -2.2% (67 calls)
in progress (365j)
matures : Aug 10, 23
matures : Aug 10, 23
SVB Leerink
May 12, 22
■ Market Perform neutral · not a buy · 🎯$20
Price at call : $17.69 — gap to target +13%
Today : $26.61 — gap to target -25%
🎯 on MD : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 12, 23
matures : May 12, 23
Credit Suisse
May 3, 22
▲ Outperform · 🎯$30
Price at call : $18.94 — upside +58%
Today : $26.61 — upside +13%
Expected +58% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on MD : 0% (6 calls matureds) · 📊 unranked overall
-26.2%
stock -26% · XLV +3%
matured May 3, 23
■ Neutral neutral · not a buy · 🎯$23
Price at call : $18.94 — gap to target +21%
Today : $26.61 — gap to target -14%
🎯 on MD : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : May 2, 23
matures : May 2, 23
SVB Leerink
Apr 27, 22
■ Market Perform neutral · not a buy · 🎯$24
Price at call : $22.72 — gap to target +6%
Today : $26.61 — gap to target -10%
🎯 on MD : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Apr 27, 23
matures : Apr 27, 23
Credit Suisse
Feb 23, 22
▲ Outperform · 🎯$31
Price at call : $23.69 — upside +31%
Today : $26.61 — upside +16%
Expected +31% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on MD : 0% (6 calls matureds) · 📊 unranked overall
-34.0%
stock -34% · XLV +1%
matured Feb 23, 23
Credit Suisse
Dec 22, 21
▲ Outperform · 🎯$32
Price at call : $26.99 — upside +19%
Today : $26.61 — upside +20%
Expected +19% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on MD : 0% (6 calls matureds) · 📊 unranked overall
-43.2%
stock -43% · XLV -2%
matured Dec 22, 22
SVB Leerink
Nov 4, 21
■ Market Perform neutral · not a buy · 🎯$27
Price at call : $27.16 — gap to target -1%
Today : $26.61 — gap to target +1%
🎯 on MD : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 4, 22
matures : Nov 4, 22
▲ Buy · 🎯$75
Price at call : $62.73 — upside +20%
Today : $26.61 — upside +182%
Expected +20% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
-29.6%
stock -30% · XLV +9%
matured Aug 26, 17
▲ Buy · 🎯$80
Price at call : $67.89 — upside +18%
Today : $26.61 — upside +201%
Expected +18% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
+2.4%
stock +2% · XLV -4%
matured Jan 30, 16
▲ Buy · 🎯$69
Price at call : $60.65 — upside +14%
Today : $26.61 — upside +159%
Expected +14% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
+20.5%
stock +21% · XLV +28%
matured Apr 18, 15
▲ Buy · 🎯$54
Price at call : $46.6 — upside +16%
Today : $26.61 — upside +103%
Expected +16% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
+22.9%
stock +23% · XLV +19%
matured May 28, 14
▲ Buy · 🎯$47.5
Price at call : $42.09 — upside +13%
Today : $26.61 — upside +79%
Expected +13% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
+25.6%
stock +26% · XLV +34%
matured Jan 4, 14
▲ Buy · 🎯$47.5
Price at call : $41.6 — upside +14%
Today : $26.61 — upside +79%
Expected +14% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
+27.0%
stock +27% · XLV +35%
matured Jan 4, 14
▲ Buy · 🎯$44
Price at call : $37.81 — upside +16%
Today : $26.61 — upside +65%
Expected +16% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on MD : 90% (10 calls matureds) · 📊 on Health : 49.6% · +9.4% (137 calls)
+33.4%
stock +33% · XLV +29%
matured Sep 19, 13
Frequently asked questions
Should I buy Pediatrix Medical Group stock?
This isn't buy advice. For Pediatrix Medical Group, the analyst consensus is "Hold", with an average price target of $28.00 (+5% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Pediatrix Medical Group). We show the numbers — you decide.
Is it too late to buy Pediatrix Medical Group? How high can it go?
The most bullish analyst target on Pediatrix Medical Group is $28.00 (+5% above today's price); the average is $28.00. That's the upside they see. Check how reliable those analysts have actually been on Pediatrix Medical Group on our site before trusting it.
Is Pediatrix Medical Group still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Pediatrix Medical Group, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
What has Pediatrix Medical Group's past performance been?
Historical returns and a "how much if I had invested" calculator: MD performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX